TrialPsychopharmacology2022

Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study.

Makoto Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.